Life Technologies | LIFE

Stock Price
5.61
Daily Change
0.14 2.56%
Monthly
5.06%
Yearly
198.40%
Q3 Forecast
5.56

Peers Price Chg Day Year Date
Ardelyx 6.52 -0.05 -0.76% 16.43% Sep/05
Biogen 140.67 0.73 0.52% -30.02% Sep/05
Bristol-Myers Squibb 47.14 0.45 0.96% -3.28% Sep/05
Clal Biotechnology 32.00 0.40 1.27% -17.53% Sep/04
Compugen 479.60 -2.50 -0.52% -33.09% Sep/04
Cipla 1,553.40 -24.40 -1.55% -3.58% Sep/05
CSL 209.25 -1.60 -0.76% -31.17% Sep/05
Galapagos 28.44 1.84 6.92% 11.53% Sep/06
Grifols 10.13 0.23 2.32% 19.32% Sep/05
GlaxoSmithKline 1,476.00 7.00 0.48% -10.63% Sep/05
Life Technologies 5.61 0.14 2.56% 198.40% Sep/05
Novartis 103.98 0.06 0.06% 5.46% Sep/05
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
United Therapeutics 400.52 20.05 5.27% 15.88% Sep/05


Life Technologies traded at $5.61 this Friday September 5th, increasing $0.14 or 2.56 percent since the previous trading session. Looking back, over the last four weeks, Life Technologies gained 5.06 percent. Over the last 12 months, its price rose by 198.40 percent. Looking ahead, we forecast Life Technologies to be priced at 5.56 by the end of this quarter and at 5.43 in one year, according to Trading Economics global macro models projections and analysts expectations.

aTyr Pharma Inc is a United States-based biotechnology company. The Company engaged in the development of medicines based on biology. The Company’s research and development efforts are concentrated on a new discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.